The purpose of this study is to identify the various factors associated with the patients' return-to-work. For conducting the study, 511 samples are selected from nine industrial accident hospitals. Questionnaire are patient's general characteristics. injury characteristics and job characteristics. These results can be summarized as follows. When industrial accident patients get older, have family members to be supported, are hospitalized for less than six months, have accidents caused by their mistakes, have worked in the construction and manufacturing industry, have worked a company with more than 300 workers, and have worked for six months~ two years or over two years, they tend to express stronger willingness of return-to-work. In face with the current drastic increase of economic loss from industrial accidents, it is required to be dealt with these factors in planning and managing the health care of industrial accident patients.
Accidents, Occupational* ; Delivery of Health Care ; Humans ; Questionnaires ; Return to Work*

It is essential during extracorporeal membrane oxygenation (ECMO) to extend the activated clotting time (ACT) using anticoagulants to prevent blood clot formation. Traditionally, heparin has been used as an anticoagulant during ECMO. Hemorrhaging due to systemic heparinization is considered a major complication of ECMO. A 48-year-old man was admitted due to cardiogenic shock with acute myocardial infarction. ECMO was instituted because of recurrent ventricular tachycardia and refractory shock. We used nafamostat mesilate (Futhan) as an anticoagulant to reduce hemorrhagic complications. The total bypass time was 153 h. The average dose of nafamostat mesilate was 2.64+/-1.11 mg/kg/h; the average ACT was 128.68+/-21.24 seconds. Only a few units were transfused, and there was no oxygenator failure or hemorrhagic complications. Thus, nafamostat mesilate may reduce the need for transfusions and hemorrhagic complications during ECMO.
Anticoagulants ; Extracorporeal Membrane Oxygenation ; Guanidines ; Hemorrhage ; Heparin ; Humans ; Mesylates ; Middle Aged ; Myocardial Infarction ; Oxygen ; Oxygenators ; Shock ; Shock, Cardiogenic ; Tachycardia, Ventricular